MedPath

Preliminary study for non-invasive measurement of estrogen receptor by [18F]FES-PET/CT

Not Applicable
Conditions
Breast cancer
Registration Number
JPRN-UMIN000019336
Lead Sponsor
Saitama Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patient who is pregnant or who has the possibility of pregnancy 2) Patient who have difficulty in performing PET/CT exam by the severe pain or bad condition 3) Patient who are determined as not appropriate for attending this study by the investigators

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
a) Validity of PET imaging process, b) relationship between the uptake in 18F-FES PET/CT and the pathological expression of estrogen receptor at primary lesion of breast cancer, and c) relationship between the uptake in 18F-FES PET/CT and the results of other imaging modalities, are evaluated by the visual comparison by radiologists and statistical analysis by the results of pathology and other imaging modalities, when 18F-FES PET/CT images of all the cases will be acquired.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath